journal article·2026-01Open access

Coupling syringe system comprising drug nanosuspension and photo-crosslinked gelatin methacryloyl hydrogel for subcutaneous delivery with decreased initial exposure

Min Young Jeong, Hye Rim Kim, Jun Soo Park, Chae Won Park, In Gyu Yang, Gi Yeong Lee, Ji Won Yeo, Ji Seong Kim, Min Kyeong Kwon, Ye Bin Shin, Yong Seok Choi, Myung Joo Kang

Materials & Design· Volume 261

Abstract

A novel, ready-to-use coupling syringe system comprising drug nanosuspensions (NSs) and photo-crosslinked gelatin methacryloyl (GelMA) hydrogels was constructed for prolonged subcutaneous drug delivery with reduced initial burst release. Three poorly water-soluble drugs—dutasteride (DTS), donepezil (DNP), and rotigotine (RTG)—were formulated into uniform NSs using a bead milling process, with mean particle sizes of 371.3, 338.7, and 769.2 nm, respectively. GelMA hydrogels were synthesized via photo-crosslinking with eosin Y and triethanolamine as initiators, adjusting rheological properties, swelling behavior, and biodegradation rates. The DTS-, DNP-, and RTG-loaded NSs were uniformly incorporated into GelMA hydrogels using a two-syringe mixing process, resulting in significantly sustained in vitro drug release under sink conditions and localized in vivo retention at the injection sites. Notably, NS-loaded GelMA hydrogels showed reduced initial systemic exposure compared to NS alone, while achieving comparable overall systemic exposure following a single subcutaneous injection in rats. This ready-to-use hydrogel system offers a simple and effective platform for parenteral delivery, addressing the limitations of conventional nanosystems associated with burst release.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Hydrogels: synthesis, properties, applications · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (86)

Show source-provided references
1. Patient-centric long-acting injectable and implantable platforms – an industrial perspective
2. Impact of jet pulverization and wet milling techniques on properties of aripiprazole long-acting injection and absorption mechanism research in vivo
3. Comparison of in vivo behaviors of intramuscularly long acting celecoxib nanosuspensions with different particle sizes for the postoperative pain treatment10.1016/j.ijpharm.2023.122793 ↗
4. Predicting the temperature evolution during nanomilling of drug suspensions via a semi theoretical lumped parameter model10.3390/pharmaceutics14122840 ↗
5. Nanocrystals based pulmonary inhalation delivery system: advance and challenge10.1080/10717544.2022.2039809 ↗
6. Emerging role of nanosuspensions in drug delivery systems10.1186/s40824-020-0184-8 ↗
7. Nanocrystals and nanosuspensions: an exploration from classic formulations to advanced drug delivery systems10.1007/s13346-024-01559-0 ↗
8. Understanding the burst release phenomenon: toward designing effective nanoparticulate drug-delivery systems10.4155/tde-2020-0099 ↗
9. Overcoming barriers by local drug delivery with liposomes10.1016/j.addr.2021.01.019 ↗
10. Internal-external homologous drug-loaded exosome-like nanovesicles released from semi-IPN hydrogel enhancing wound healing of chemoradiotherapy-induced oral mucositis10.2147/IJN.S508530 ↗
11. 5-Fluorouracil-loaded green chitosan nanoparticles/guar gum nanocomposite hydrogel in controlled drug delivery10.1016/j.carres.2024.109257 ↗
12. Fabrication of lipid-modified drug nanocrystals loaded injectable hydrogel for breast cancer therapy10.1186/s11671-025-04195-w ↗
13. New insights into nanocomposite hydrogels; a review on recent advances in characteristics and applications
14. Dexamethasone nanocrystals-embedded hydroxypropyl methylcellulose hydrogel increases cochlear delivery and attenuates hearing loss following intratympanic injection10.1016/j.carbpol.2024.122546 ↗
15. Biomedical applications of functional hydrogels: innovative developments, relevant clinical trials and advanced products10.1016/j.biomaterials.2024.122718 ↗
16. Regenerative medicine: hydrogels and mesoporous silica nanoparticles
17. In-situ forming PLGA implants: towards less toxic solvents10.1016/j.ijpharm.2024.124121 ↗
18. Long-acting injectable delivery system comprising ordered mixed drug aggregates with deaggregating and uniformly embeddable viscoelastic -polysaccharide solutions10.1016/j.carbpol.2025.123682 ↗
19. Microcrystal delivery using a syringe and syringe pump method for serial crystallography10.3390/analytica6010005 ↗
20. Injectable in-situ forming depot based on PLGA and PLGA-PEG-PLGA for sustained-release of risperidone: in vitro evaluation and pharmacokinetics in rabbits10.3390/pharmaceutics15041229 ↗
21. An overview on common organic solvents and their toxicity10.9734/jpri/2019/v28i330203 ↗
22. Exposure to the bromodomain inhibitor N-methyl pyrrolidone blocks spermatogenesis in a hormonal and non-hormonal fashion10.1016/j.taap.2021.115568 ↗
23. Unveiling the versatility of gelatin methacryloyl hydrogels: a comprehensive journey into biomedical applications10.1088/1748-605X/ad4df7 ↗
24. Photocrosslinkable gelatin hydrogel for epidermal tissue engineering10.1002/adhm.201500005 ↗
25. Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels10.1016/j.biomaterials.2015.08.045 ↗
26. R.N. Ghosh, J. Thomas, V.B. R., N.G. Devi, A. Janardanan, P.K. Namboothiri, M. Peter, An insight into synthesis, properties and applications of gelatin methacryloyl hydrogel for 3D bioprinting, Mater. Adv. 4 (2023) 5496–5529. https://doi.org/10.1039/D3MA00715D.10.1039/D3MA00715D ↗
27. Gelatin methacryloyl hydrogels control the localized delivery of albumin-bound paclitaxel10.3390/polym12020501 ↗
28. GelMA–based bioactive hydrogel scaffolds with multiple bone defect repair functions: therapeutic strategies and recent advances10.1186/s40824-023-00422-6 ↗
29. Avodart® FDA Biopharmaceutics Review, Available online: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21319_Duagen_biopharmr_P1.pdf (accessed June 17, 2025).
30. Donepezil—an updated review of challenges in dosage form design
31. Rotigotine: a review of analytical methods for the raw material, pharmaceutical formulations, and its impurities10.1093/jaoacint/qsaa145 ↗
32. U.S. Food and Drug Administration, Aricept® (donepezil hydrochloride) (NDA 020690 & 021720 & 022568), 1996. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020690s035,021720s008,022568s005lbl.pdf.
33. U.S. Food and Drug Administration, Neupro® (rotigotine transdermal system) (NDA 021829), 2012. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/021829Orig1s001s002.pdf.
34. Controlled release of dutasteride from biodegradable microspheres: in vitro and in vivo studies10.1371/journal.pone.0114835 ↗
35. Preparation and evaluation of rotigotine-loaded implant for the treatment of Parkinson’s disease and its evolution study10.1016/j.jsps.2016.04.022 ↗
36. Preparation and evaluation of injectable microsphere formulation for longer sustained release of donepezil10.1016/j.jconrel.2023.02.024 ↗
37. Suspected donepezil toxicity: a case report10.1002/ccr3.3245 ↗
38. Dissolving microarray patches loaded with a rotigotine nanosuspension: a potential alternative to Neupro® patch10.1016/j.jconrel.2024.06.039 ↗
39. Carboxymethyl cellulose-based rotigotine nanocrystals-loaded hydrogel for increased transdermal delivery with alleviated skin irritation10.1016/j.carbpol.2024.122197 ↗
40. In vitro and in vivo analysis of visible light crosslinkable gelatin methacryloyl (GelMA) hydrogels10.1039/C7BM00110J ↗
41. Tuning gelatin-based hydrogel towards bioadhesive ocular tissue engineering applications
42. Ionic effects on the mechanical and swelling properties of a poly(acrylic acid/acrylamide) double crosslinking hydrogel10.1039/C8NJ00920A ↗
43. Enzymatic post-crosslinking of printed hydrogels of methacrylated gelatin and tyramine-conjugated 8-arm poly(ethylene glycol) to prepare interpenetrating 3D network structures10.18063/ijb.750 ↗
44. Single color digital H&E staining with In-and-out net
45. A method to monitor dutasteride in rat plasma using liquid-liquid extraction and multiple reaction monitoring: comparisons and validation10.5478/MSL.2014.5.3.79 ↗
46. Optimized method development and validation for determining donepezil in rat plasma: a liquid–liquid extraction, LC–MS/MS, and design of experiments approach10.1371/journal.pone.0309802 ↗
47. A sensitive, efficient, and cost-effective method to determine rotigotine in rat plasma using liquid-liquid extraction (LLE) and LC-MRM
48. Designing hydrogels for controlled drug delivery10.1038/natrevmats.2016.71 ↗
49. Engineering biodegradable and biocompatible bio-ionic liquid conjugated hydrogels with tunable conductivity and mechanical properties10.1038/s41598-017-04280-w ↗
50. Visible light photoinitiation of mesenchymal stem cell-laden bioresponsive hydrogels10.22203/eCM.v022a04 ↗
51. Yield-stress and creep control depot formation and persistence of injectable hydrogels following subcutaneous administration10.1002/adfm.202203402 ↗
52. Engineering the viscoelasticity of gelatin methacryloyl (GelMA) hydrogels via small “dynamic bridges” to regulate BMSC behaviors for osteochondral regeneration
53. Eosin Y derivatives for visible light-mediated free-radical polymerization: applications in 3D-photoprinting and bacterial photodynamic inactivation10.1016/j.eurpolymj.2024.113143 ↗
54. Role of polymer concentration and crosslinking density on release rates of small molecule drugs10.3390/ijms23084118 ↗
55. A recent overview of surfactant–drug interactions and their importance10.1039/D3RA02883F ↗
56. Preparation of carbohydrate-based functional composite films incorporated with curcumin10.1016/j.foodhyd.2019.105302 ↗
57. Y. Zhang, L. Huang, Z. Deng, B. Luo, Y. Cui, Drug nanocrystals: Surface engineering and its applications in targeted delivery, iScience 27 (2024) 111185. .10.1016/j.isci.2024.111185 ↗
58. Nanoparticle preparation of pharmaceutical compounds via wet milling: current status and future prospects10.1016/j.powtec.2024.119430 ↗
59. Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: insights for applications in HIV therapy10.1016/j.addr.2016.02.003 ↗
60. Design of nanocrystalline suspension of dutasteride for intramuscular prolonged delivery10.3390/nano14221781 ↗
61. Tuning physical properties of GelMA hydrogels through microarchitecture for engineering osteoid tissue10.1021/acs.biomac.3c00909 ↗
62. Injectable shear-thinning hydrogels for minimally invasive delivery to infarcted myocardium to limit left ventricular remodeling10.1161/CIRCINTERVENTIONS.116.004058 ↗
63. Mechanisms of degradation of collagen or gelatin materials (hemostatic sponges) in oral surgery: a systematic review10.3390/surgeries5030043 ↗
64. Nanosizing techniques for improving bioavailability of drugs10.1016/j.jconrel.2017.06.003 ↗
65. Local confinement controls diffusive nanoparticle dynamics in semidilute polyelectrolyte solutions10.1021/acs.langmuir.0c01402 ↗
66. Visualisation and quantification of subcutaneous injections of different volumes, viscosities and injection rates: an ex-vivo micro-CT study10.1016/j.xphs.2024.08.019 ↗
67. Controlled release and targeted drug delivery with poly(lactic-co-glycolic acid) nanoparticles: reviewing two decades of research10.1007/s40005-022-00584-w ↗
68. A new near-infrared fluorescence probe synthesized from IR-783 for detection and bioimaging of hydrogen peroxide in vitro and in vivo10.1016/j.saa.2021.120642 ↗
69. Gelatin methacryloyl hydrogel, from standardization, performance, to biomedical application10.1002/adhm.202300395 ↗
70. Gelatin methacryloyl (GelMA) loaded with concentrated hypoxic pretreated adipose-derived mesenchymal stem cells (ADSCs) conditioned medium promotes wound healing and vascular regeneration in aged skin10.1186/s40824-023-00352-3 ↗
71. Gelatin–based biomaterials and gelatin as an additive for chronic wound repair10.3389/fphar.2024.1398939 ↗
72. Control of matrix stiffness using methacrylate–gelatin hydrogels for a macrophage–mediated inflammatory response10.1021/acsbiomaterials.0c00295 ↗
73. Hydrogel crosslinking modulates macrophages, fibroblasts, and their communication, during wound healing10.1038/s41467-024-50072-y ↗
74. Effect of tunable stiffness on immune responses in 3D‑bioprinted alginate–gelatin scaffolds10.36922/ijb.2874 ↗
75. Gelatin methacryloyl hydrogels for musculoskeletal tissue regeneration10.3390/bioengineering9070332 ↗
76. Self–aggregating long–acting injectable microcrystals10.1038/s44286-025-00194-x ↗
77. Effect of dispersion medium on pharmacokinetic profile of rotigotine crystalline suspension following subcutaneous injection10.3390/pharmaceutics14122630 ↗
78. Gelatin–based hydrogel degradation and tissue interaction in vivo: insights from multimodal preclinical imaging in immunocompetent nude mice10.7150/thno.16614 ↗
79. Multifunctional two–component in–situ hydrogel for esophageal submucosal dissection for mucosa uplift, postoperative wound closure and rapid healing
80. R.A. Al-Horani, P. Patel, Dutasteride, in: StatPearls [Internet], StatPearls Publishing, 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK603726/.
81. A. Kumar, V. Gupta, S. Sharma, Donepezil, in: StatPearls [Internet], StatPearls Publishing, 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513257/.
82. Crushed tablet administration for patients with dysphagia and enteral feeding: challenges and considerations10.1007/s40266-023-01056-y ↗
83. The psychological impacts of pill dysphagia: a mixed methods study10.1007/s00455-024-10703-4 ↗
84. A noninterventional study evaluating the effectiveness of rotigotine and levodopa combination therapy in younger versus older patients with Parkinson’s disease10.1080/14656566.2018.1480721 ↗
85. Rotigotine transdermal patch: a review in Parkinson’s disease10.1007/s40263-019-00646-y ↗
86. Challenges in the development of long acting injectable multivesicular liposomes (DepoFoam® technology)10.1016/j.ejpb.2024.114577 ↗